Editas Medicine, Inc. (EDIT)
2.25
+0.13
(+6.13%)
USD |
NASDAQ |
Jan 22, 10:07
Editas Medicine Price: 2.25 for Jan. 22, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| ADMA Biologics, Inc. | 17.51 |
| Arcutis Biotherapeutics, Inc. | 26.68 |
| Daré Bioscience, Inc. | 1.96 |
| Cogent Biosciences, Inc. | 39.52 |
| Janux Therapeutics, Inc. | 13.78 |
Price Related Metrics
| PS Ratio | 4.125 |
| Price to Book Value | 16.33 |
| Earnings Yield | -105.7% |
| Market Cap | 219.64M |